Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...
The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...
The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.
ARE should gain from the solid demand for top-quality life science assets in key markets, though a vast development outlay ...
U.S. stock indexes are drifting around their records as hopes hold that the economy can pull off the feat of getting ...
U.S. equities were mixed at midday as the Federal Reserve's favored measure of inflation was lower than anticipated.
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of stock of Metagenomi, Inc. pursuant and/or traceable to the Company's ...
The blue-chip Dow rose on Friday to hit an intraday record and small-cap stocks outperformed after a benign inflation report ...
ABC News' Linsey Davis speaks with White House National Security spokesman John Kirby on the latest in the cease-fire negotiations between Lebanon and Israel as tensions escalate in the region.
Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval on Thursday for its groundbreaking ...
The U. S. Food and Drug Administration (FDA) has signed off on Cobenfy, the first revolutionary treatment for schizophrenia ...
A leading rights group says Rwanda’s army and a militia it backs shelled camps for displaced people in eastern Congo. Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback